StockData
Pliant Therapeutics, Inc. logo

Pliant Therapeutics, Inc. (PLRX) stock

PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 3/30
$0.66+0.00 (+0.12%)

Close on Nov 18, 2026Market cap $40.93MP/E –Yield 0.00%

Pliant Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Pliant Therapeutics's price to sales ratio was 448.3× on Apr 30, 2024, against 161.0× a year earlier. Over the last 3 years it ranged from 27.9× to 448.3×, with a median of 76.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Apr 30, 2024448.3×+142.3
2023Dec 29, 2023306.0×+209.0
2022Dec 30, 202297.0×+48.6
2021Dec 31, 202148.4×–

More Pliant Therapeutics figures

See a number that looks wrong?